Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
LuciA-15 - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genes.
Ecancermedicalscience. 2023 Nov 21;17:1634. doi: 10.3332/ecancer.2023.1634. eCollection 2023.
Ecancermedicalscience. 2023.
PMID: 38414929
Free PMC article.
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review.
Narvaez D, Nadal J, Nervo A, Costanzo MV, Paletta C, Petracci FE, Rivero S, Ostinelli A, Freile B, Enrico D, Pombo MT, Amat M, Aguirre ED, Chacon M, Waisberg F.
Narvaez D, et al. Among authors: petracci fe.
Cancers (Basel). 2024 Jan 17;16(2):396. doi: 10.3390/cancers16020396.
Cancers (Basel). 2024.
PMID: 38254885
Free PMC article.
Review.
Item in Clipboard
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.
Al Sukhun S, Temin S, Barrios CH, Antone NZ, Guerra YC, Chavez-MacGregor M, Chopra R, Danso MA, Gomez HL, Homian NM, Kandil A, Kithaka B, Koczwara B, Moy B, Nakigudde G, Petracci FE, Rugo HS, El Saghir NS, Arun BK.
Al Sukhun S, et al. Among authors: petracci fe.
JCO Glob Oncol. 2024 Jan;10:e2300285. doi: 10.1200/GO.23.00285.
JCO Glob Oncol. 2024.
PMID: 38206277
Free PMC article.
Item in Clipboard
Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates.
González-Hurtado D, Rivero S, Samamé Pérez-Vargas JC, Petracci FE.
González-Hurtado D, et al. Among authors: petracci fe.
Breast Cancer (Auckl). 2023 Aug 23;17:11782234231192780. doi: 10.1177/11782234231192780. eCollection 2023.
Breast Cancer (Auckl). 2023.
PMID: 37637230
Free PMC article.
Review.
Item in Clipboard
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2.
Narváez D, Waisberg F, Soulé T, Angel M, Bruno L, Girotti MR, Pupareli C, Chacón M, Petracci FE.
Narváez D, et al. Among authors: petracci fe.
Ecancermedicalscience. 2022 Sep 26;16:1448. doi: 10.3332/ecancer.2022.1448. eCollection 2022.
Ecancermedicalscience. 2022.
PMID: 36405946
Free PMC article.
Item in Clipboard
Cite
Cite